Style | Citing Format |
---|---|
MLA | Javandoost E, et al.. "Role of Micrornas in Chronic Lymphocytic Leukemia Pathogenesis." Current Medicinal Chemistry, vol. 27, no. 2, 2020, pp. 282-297. |
APA | Javandoost E, Firoozimajd E, Rostamian H, Khakpoorkoosheh M, Mirzaei HR (2020). Role of Micrornas in Chronic Lymphocytic Leukemia Pathogenesis. Current Medicinal Chemistry, 27(2), 282-297. |
Chicago | Javandoost E, Firoozimajd E, Rostamian H, Khakpoorkoosheh M, Mirzaei HR. "Role of Micrornas in Chronic Lymphocytic Leukemia Pathogenesis." Current Medicinal Chemistry 27, no. 2 (2020): 282-297. |
Harvard | Javandoost E et al. (2020) 'Role of Micrornas in Chronic Lymphocytic Leukemia Pathogenesis', Current Medicinal Chemistry, 27(2), pp. 282-297. |
Vancouver | Javandoost E, Firoozimajd E, Rostamian H, Khakpoorkoosheh M, Mirzaei HR. Role of Micrornas in Chronic Lymphocytic Leukemia Pathogenesis. Current Medicinal Chemistry. 2020;27(2):282-297. |
BibTex | @article{ author = {Javandoost E and Firoozimajd E and Rostamian H and Khakpoorkoosheh M and Mirzaei HR}, title = {Role of Micrornas in Chronic Lymphocytic Leukemia Pathogenesis}, journal = {Current Medicinal Chemistry}, volume = {27}, number = {2}, pages = {282-297}, year = {2020} } |
RIS | TY - JOUR AU - Javandoost E AU - Firoozimajd E AU - Rostamian H AU - Khakpoorkoosheh M AU - Mirzaei HR TI - Role of Micrornas in Chronic Lymphocytic Leukemia Pathogenesis JO - Current Medicinal Chemistry VL - 27 IS - 2 SP - 282 EP - 297 PY - 2020 ER - |